跳至主要内容
临床试验/ACTRN12620001176954
ACTRN12620001176954尚未招募未知

Efficacy and Feasibility of Early Intervention with Catheter Ablation (CA) compared to anti-arrhythmic drugs (AADs) alone for Management of Ventricular Tachycardia (VT) storm

Western Sydney Local Health District0 个研究点目标入组 150 人开始时间: 2020年11月9日最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Patients will be eligible for inclusion if they have/are:
  • 1.Age greater than or equal to 18 years;
  • 2.VT storm due to sustained monomorphic VT (MMVT), confirmed on 12-lead ECG or implanted cardiac device which may include an implanted cardioverter defibrillator (ICD), cardiac pacemaker, loop recorder, cardiac resynchronisation therapy device or detected on a Holter monitor or during an exercise stress test;
  • 3.Patients with VT storm defined as incessant VT or 3 or more isolated episodes of VT appropriately treated by their ICD or VT requiring external or pharmacological attempts at reversion to the patient’s baseline rhythm;
  • 4.Informed consent able to be provided to be in the trial

排除标准

  • Patients will be excluded if they have/are:
  • 1.Concomitant illness, physical impairment or mental condition which in the opinion of the study team/primary care physician could interfere with the conduct of the study including outcome assessments;
  • 2.Pregnant and/or breastfeeding
  • 3.Unable or unwilling to provide informed consent
  • 4.Unable or unwilling to complete study procedures or attend clinic follow up

研究者

相似试验